- Home
- EKSO vs RAND Comparison
EKSO vs RAND Comparison
Compare EKSO & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EKSO | RAND |
|---|---|---|
| Founded | 2005 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 34.6M |
| IPO Year | 2012 | 1996 |
Fundamental Metrics
Financial Performance| Metric | EKSO | RAND |
|---|---|---|
| Price | $10.01 | $11.69 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 70.0K | 4.5K |
| Earning Date | 05-04-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 10.08% |
| EPS Growth | ★ 41.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $81.23 | N/A |
| Revenue Next Year | $7.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $10.05 |
| 52 Week High | $13.50 | $21.30 |
Technical Indicators
Market Signals| Indicator | EKSO | RAND |
|---|---|---|
| Relative Strength Index (RSI) | 43.96 | 55.56 |
| Support Level | $9.64 | $10.37 |
| Resistance Level | $10.76 | $12.50 |
| Average True Range (ATR) | 0.90 | 0.59 |
| MACD | -0.18 | 0.04 |
| Stochastic Oscillator | 0.00 | 84.18 |
Price Performance
Historical ComparisonAbout EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. Its investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.